Press "Enter" to skip to content

New patent for Taiho Oncology drug LONSURF

0
Copyright © DrugPatentWatch. Originally published at New patent for Taiho Oncology drug LONSURF

Annual Drug Patent Expirations for LONSURF
Annual Drug Patent Expirations for LONSURF

Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has sixty-six patent family members in twenty-nine countries.

The generic ingredient in LONSURF is tipiracil hydrochloride; trifluridine. One supplier is listed for this compound. Additional details are available on the tipiracil hydrochloride; trifluridine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Taiho Oncology drug LONSURF
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions